Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01980225
Other study ID # VanLanduyt2013
Secondary ID
Status Completed
Phase N/A
First received October 28, 2013
Last updated June 8, 2015
Start date November 2011
Est. completion date August 2014

Study information

Verified date June 2015
Source Centre for Reproductive Medicine, Belgium
Contact n/a
Is FDA regulated No
Health authority Belgium: Federal Agency for Medicinal Products and Health Products
Study type Interventional

Clinical Trial Summary

In our centre, the implantation rate of frozen blastocysts (cryopreserved using vitrification)was 20,3% (Van Landuyt et al. 2011). This implantation rate is lower when compared to data from other observational studies. Retrospective studies have shown that artificial shrinkage of the blastocoelic cavity (also called collapse) and dehydration of the blastocyst just before vitrification can have a positive effect on the survival after warming. This collapse can be induced by using a laser. The study of Iwayama et al. 2010 has shown a similar survival rate but an increase in the implantation rate of collapsed blastocysts compared to non-collapsed blastocysts.

The aim of the study is to investigate the effect of artificial shrinkage by laser-induced collapse on the implantation potential of vitrified-warmed day 5 or day 6 blastocyst stage embryos in a prospective randomised controlled trial.


Recruitment information / eligibility

Status Completed
Enrollment 270
Est. completion date August 2014
Est. primary completion date August 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 38 Years
Eligibility Inclusion Criteria:

- female age <39 years

- at least 1 blastocyst available for cryopreservation

Exclusion Criteria:

- sperm origin: testicular or epididymal sperm extraction

- IVM (in-vitro maturation) cycles

- PGD cycles (preimplantation genetic diagnosis)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Implantation Rate of Vitrified Blastocysts

Intervention

Procedure:
Collapse
inducing collapse (= artificial shrinkage) by applying 1 or 2 laser pulses between trophectoderm cells of the blastocyst to be vitrified

Locations

Country Name City State
Belgium Centre for Reproductive Medicine Brussels

Sponsors (1)

Lead Sponsor Collaborator
Centre for Reproductive Medicine, Belgium

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary implantation rate of the embryo in the first frozen transfer cycle patients are enrolled in the study at oocyte retrieval. When patient is not pregnant after fresh embryo transfer, she comes back to use the frozen embryos at least one month after the initial inclusion. After the frozen embryo transfer, poshCG is measured 14 days after transfer. Approximately 10 weeks after transfer, implantation rate of the frozen embryos is assessed. This is the number of intra-uterine gestational sacs seen on ultrasound on the number of embryos transferred approximately 10 weeks after the first frozen embryo transfer No
Secondary survival rate of warmed blastocysts this is the morphological assessment of survival of the blastocyst after warming 0-30 minutes No
Secondary implantation rate per warmed blastocyst implantation rate of the transferred embryo per embryo initially warmed in that frozen transfer cycle. approximately 10 weeks after first frozen transfer No